looking for advise18 Apr 2018 13:47
after getting burnt in IMM, my first pharma stock, now trying to recover that money if possible in Motif due to the successful P3 results compared to IMM but wondering why the SP is so low here after successful P3 results?
I see that NDA got delayed but I think before the delay announcement as well, the SP wasn't near to its peak of 62p?
May be we could see a rise after NDA submission? FDA granted Fast track status to Motif!
In one of the RNS they mentioned that approval could be in fourth quarter 2018 so may be big IIs are waiting till the approval?
Also I see that Amphion are one of the major stakeholders in MOTIF. It appears like Amphion may sell their stake here anytime to sustain their own business? see below from the Amphion RNS about their loan restructure -
"
Under the terms of the Additional Draw, the interest rate will be 10%. The Lender will also receive 10% of the appreciation on 12,000,000 ordinary shares of Motif Bio plc above 35 pence. The proceeds are to be used for working capital for Amphion and its Partner Companies.
The current loan under the Facility continues to be secured by the pledge by the Company of 36,371,625 ordinary shares of Motif Bio plc. Amphion has transferred the legal title to, but retains the beneficial interest in, the total pledged shares. The Lender has agreed not to sell any ordinary shares of Motif Bio plc until 15 June 2018 as long as the Company remains in compliance with the terms of the Facility.
"